Skip to main content
. Author manuscript; available in PMC: 2020 Jan 2.
Published in final edited form as: J Clin Immunol. 2019 May 14;39(4):440–447. doi: 10.1007/s10875-019-00640-5

Table 3.

Clinical and laboratory comparison between CVID with and without ILD

+ILD
N = 107
−ILD
N = 642
P value*
Sex = male (%) 47 (43.9) 275 (42.8) 0.916
Age at last visit 38.20 [28.35, 49.10] 39.55 [24.05, 50.80] 0.764
Age of symptom onset 16.00 [11.10, 27.00] 16.00 [6.00, 31.00] 0.747
Age of diagnosis 29.80 [20.92, 37.75] 29.90 [14.65, 43.10] 0.968
CD4 565.00 [366.00, 773.00] 687.00 [474.50, 944.75] 0.005
CD8 244.50 [160.75, 409.50] 433.00 [290.00, 697.00] < 0.001
CD19 85.50 [19.25, 226.00] 198.00 [91.50, 323.00] < 0.001
Pre-diagnostic IgG 277 [97.5–389.5] 374.4 [194.5–535.75] 0.009
IgA 7.00 [6.00, 21.00] 10.00 [6.67, 33.00] 0.05
IgM 21.45 [9.00, 42.50] 23.00 [11.00, 44.25] 0.631
Pneumonia 84 (78.5%) 390 (60.7%) < 0.001
Bronchiectasis 27 (25.2%) 74 (11.5%) < 0.001
Sinusitis 82 (76.6) 494 (76.9%) 1
URT 59 (55.1%) 364 (56.7%) 0.845
*

Statistical analysis was performed using Chi-square test for categorical variables and Mann-Whitney test for continuous variables

Continuous variables were summarized as median [IQR] and categorical variables were summarized as counts (percentage)